Arjo AB (publ) (ARJO-B) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Arjo AB (publ) (ARJO-B) has a cash flow conversion efficiency ratio of 0.033x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr257.00 Million ≈ $27.66 Million USD) by net assets (Skr7.76 Billion ≈ $834.78 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of Arjo AB (publ) for the company's overall valuation and market capitalisation.
Arjo AB (publ) - Cash Flow Conversion Efficiency Trend (2014–2025)
This chart illustrates how Arjo AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data.
Arjo AB (publ) Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Arjo AB (publ) ranked by their cash flow conversion efficiency. Explore ARJO-B operating cash flow to net income to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
WELL Health Technologies Corp
TO:WELL
|
0.090x |
|
Solarvest Holdings Bhd
KLSE:0215
|
-0.079x |
|
Eagle Bancorp Inc
NASDAQ:EGBN
|
-0.030x |
|
Jiangsu Rainbow Heavy Industries Co Ltd
SHE:002483
|
0.014x |
|
Hanilcmt Co Ltd
KO:300720
|
0.053x |
|
Daily Journal Corp
NASDAQ:DJCO
|
0.032x |
|
Hunan Jiudian Pharmaceutical Co Ltd
SHE:300705
|
0.063x |
|
Navigator Global Investments Ltd
AU:NGI
|
0.054x |
Annual Cash Flow Conversion Efficiency for Arjo AB (publ) (2014–2025)
The table below shows the annual cash flow conversion efficiency of Arjo AB (publ) from 2014 to 2025. View current stock price of Arjo AB (publ) for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Skr7.46 Billion ≈ $802.49 Million |
Skr1.44 Billion ≈ $154.43 Million |
0.192x | +5.84% |
| 2024-12-31 | Skr8.34 Billion ≈ $897.30 Million |
Skr1.52 Billion ≈ $163.15 Million |
0.182x | -33.11% |
| 2023-12-31 | Skr7.58 Billion ≈ $815.94 Million |
Skr2.06 Billion ≈ $221.80 Million |
0.272x | +126.49% |
| 2022-12-31 | Skr7.62 Billion ≈ $820.46 Million |
Skr915.00 Million ≈ $98.47 Million |
0.120x | -52.35% |
| 2021-12-31 | Skr6.88 Billion ≈ $740.94 Million |
Skr1.73 Billion ≈ $186.61 Million |
0.252x | -37.45% |
| 2020-12-31 | Skr5.63 Billion ≈ $605.88 Million |
Skr2.27 Billion ≈ $243.97 Million |
0.403x | +90.20% |
| 2019-12-31 | Skr5.91 Billion ≈ $636.44 Million |
Skr1.25 Billion ≈ $134.74 Million |
0.212x | +15.93% |
| 2018-12-31 | Skr5.43 Billion ≈ $584.03 Million |
Skr991.00 Million ≈ $106.65 Million |
0.183x | +61.98% |
| 2017-12-31 | Skr5.07 Billion ≈ $546.04 Million |
Skr572.00 Million ≈ $61.56 Million |
0.113x | +30.74% |
| 2016-12-31 | Skr10.66 Billion ≈ $1.15 Billion |
Skr919.00 Million ≈ $98.90 Million |
0.086x | +8.73% |
| 2015-12-31 | Skr10.23 Billion ≈ $1.10 Billion |
Skr811.00 Million ≈ $87.28 Million |
0.079x | -12.33% |
| 2014-12-31 | Skr10.60 Billion ≈ $1.14 Billion |
Skr959.00 Million ≈ $103.20 Million |
0.090x | -- |
About Arjo AB (publ)
Arjo AB (publ) develops and sells medical devices and solutions for patients for clinical and financial outcomes for healthcare in Europe, Asia, Latin America, Africa, and the Pacific. It offers products and solutions for patient handling, hygiene, disinfection, medical beds, pressure injury prevention, diagnostics, hygiene, prevention of pressure injuries and blood clots, and leg ulcer treatment… Read more